المؤلفون: Oskarsdottir, Gudrun N., Lampa, Erik, Berglund, Anders, Rosengren, Linda, Ulvestad, Maria, Boros, Miklos, Daumont, Melinda J., Rault, Caroline, Emanuel, Gabrielle, Leal, Cátia, Schoemaker, Minouk J., Wagenius, Gunnar

المصدر: Cancers. 16(9)

مصطلحات موضوعية: I-O Optimise, non-small-cell lung cancer (NSCLC), overall survival, real-world evidence, registry, Sweden, time to next treatment or death, Medicin och hälsovetenskap, Klinisk medicin, Cancer och onkologi, Medical and Health Sciences, Clinical Medicine, Cancer and Oncology

URL الوصول: https://lup.lub.lu.se/record/fcb229de-1639-4846-979e-1cf03b03f675
http://dx.doi.org/10.3390/cancers16091655

المؤلفون: Sørensen, Jens Benn, Baas, Paul, Szépligeti, Szimonetta Komjáthiné, Pedersen, Alma B., Johnsen, Søren P., Carroll, Robert, Schoemaker, Minouk J., Rault, Caroline, Daumont, Melinda J., Ehrenstein, Vera

المصدر: Sørensen , J B , Baas , P , Szépligeti , S K , Pedersen , A B , Johnsen , S P , Carroll , R , Schoemaker , M J , Rault , C , Daumont , M J & Ehrenstein , V 2024 , ' Patient characteristics, treatment patterns, and survival outcomes for patients with malignant pleural mesothelioma in Denmark between 2011 and 2018: a nationwide population-based cohort study ' , Acta Oncologica , vol. 63 , pp. 649-657 . https://doi.org/10.2340/1651-226X.2024.34802

مصطلحات موضوعية: Aged, 80 and over, Cohort Studies, Denmark/epidemiology, Female, Humans, Lung Neoplasms/mortality, Male, Mesothelioma, Malignant/therapy, Middle Aged, Pleural Neoplasms/mortality, Registries/statistics & numerical data, Survival Rate, malignant pleural mesothelioma, registries, epidemiology, Cohort study, Denmark

وصف الملف: application/pdf

الاتاحة: https://vbn.aau.dk/da/publications/c2b024cd-99d6-4235-83de-4df377c06f65
https://doi.org/10.2340/1651-226X.2024.34802
https://vbn.aau.dk/ws/files/740602972/S_rensen_et_al._2024_._Patient_characteristics_treatment_patterns_and_survival_outcomes_for_patients_with_malignant_pleural_mesothelioma_in_Denmark_between_2011_and_2018_-_a_nationwide_population-based_cohort_study.pdf
http://www.scopus.com/inward/record.url?scp=85200939292&partnerID=8YFLogxK

المؤلفون: Cedres, Susana, Calvete, Julio, Taylor-Stokes, Gavin, Ayerza, Néstor Álvarez, Larena, David Vilanova, Daumont, Melinda

المصدر: Clinical & Translational Oncology; Jan2025, Vol. 27 Issue 1, p213-222, 10p

المؤلفون: Provencio Pulla, Mariano, Carcereny, Enric, López Castro, Rafael, Calvo, Virginia, Rodríguez Abreu, Delvys, Cobo, Manuel, Ortega, Ana Laura, Bernabé, Reyes, Guirado, Maria, Massuti Sureda, Bartomeu, Barco, Edel, Bosch Barrera, Joaquim, Camps Herrero, Carlos, Carroll, Robert, Rault, Caroline, Chaib, Carlos, Penrod, John, Vo, Lien, Ralphs, Eleanor, Daumont, Melinda

المصدر: Provencio Pulla, Mariano Carcereny, Enric López Castro, Rafael Calvo, Virginia Rodríguez Abreu, Delvys Cobo, Manuel Ortega, Ana Laura Bernabé, Reyes Guirado, Maria Massuti Sureda, Bartomeu Barco, Edel Bosch Barrera, Joaquim Camps Herrero, Carlos Carroll, Robert Rault, Caroline Chaib, Carlos Penrod, John Vo, Lien Ralphs, Eleanor Daumont, Melinda 2023 Real-world treatment patterns and survival outcomes for patients with stage III non-small cell lung cancer in Spain : a nationwide cohort study Translational Lung Cancer Research 12 10 2113 2128

مصطلحات موضوعية: Càncer Pacients, Pulmons Malalties

وصف الملف: application/pdf

Relation: Translational Lung Cancer Research, 2023, vol. 12, num. 10, p. 2113-2128; https://hdl.handle.net/10550/90967; 161680

الاتاحة: https://hdl.handle.net/10550/90967
https://doi.org/10.21037/tlcr-23-176

المؤلفون: Moore, Adam, Bennett, Bryan, Taylor-Stokes, Gavin, Daumont, Melinda J.

المساهمون: Bristol-Myers Squibb

المصدر: Quality of Life Research ; volume 32, issue 9, page 2587-2599 ; ISSN 0962-9343 1573-2649

الاتاحة: http://dx.doi.org/10.1007/s11136-023-03410-4
https://link.springer.com/content/pdf/10.1007/s11136-023-03410-4.pdf
https://link.springer.com/article/10.1007/s11136-023-03410-4/fulltext.html

المؤلفون: Wolf, Andrea, Stratmann, Jan A., Shaid, Shabnam, Niklas, Nicolas, Calleja, Alan, Ubhi, Harveen, Munro, Robin, Waldenberger, Daniela, Carroll, Robert, Daumont, Melinda J., Penrod, John R., Lacoin, Laure, Rohde, Gernot

المساهمون: Bristol Myers Squibb, Johann Wolfgang Goethe-Universität, Frankfurt am Main

المصدر: BMC Pulmonary Medicine ; volume 23, issue 1 ; ISSN 1471-2466

الاتاحة: http://dx.doi.org/10.1186/s12890-022-02288-1
https://link.springer.com/content/pdf/10.1186/s12890-022-02288-1.pdf
https://link.springer.com/article/10.1186/s12890-022-02288-1/fulltext.html

المؤلفون: Scherpereel, Arnaud, Antonia, Scott, Bautista, Yolanda, Grossi, Francesco, Kowalski, Dariusz, Zalcman, Gérard, Nowak, Anna K, Fujimoto, Nobukazu, Peters, Solange, Tsao, Anne S, Mansfield, Aaron S, Popat, Sanjay, Sun, Xiaowu, Lawrance, Rachael, Zhang, Xiaoqing, Daumont, Melinda J, Bennett, Bryan, McKenna, Mike, Baas, Paul

المساهمون: Scherpereel, Arnaud, Antonia, Scott, Bautista, Yolanda, Grossi, Francesco, Kowalski, Dariusz, Zalcman, Gérard, Nowak, Anna K, Fujimoto, Nobukazu, Peters, Solange, Tsao, Anne S, Mansfield, Aaron S, Popat, Sanjay, Sun, Xiaowu, Lawrance, Rachael, Zhang, Xiaoqing, Daumont, Melinda J, Bennett, Bryan, Mckenna, Mike, Baas, Paul

مصطلحات موضوعية: Anti-cytotoxic T lymphocyte antigen-4 (CTLA-4), EQ-5D, Immune checkpoint inhibitor, Immuno-oncology, Immunotherapy, Lung Cancer Symptom Scale, Overall survival, Programmed cell death (PD)-1 inhibitor, Quality of life, Symptom burden, Antineoplastic Combined Chemotherapy Protocol, Human, Ipilimumab, Nivolumab, Patient Reported Outcome Measure, Lung Neoplasm, Mesothelioma, Malignant

وصف الملف: ELETTRONICO

Relation: info:eu-repo/semantics/altIdentifier/pmid/35367910; info:eu-repo/semantics/altIdentifier/wos/WOS:000807516900002; volume:167; firstpage:8; lastpage:16; numberofpages:9; journal:LUNG CANCER; https://hdl.handle.net/11383/2142154; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85127301419

الاتاحة: https://hdl.handle.net/11383/2142154
https://doi.org/10.1016/j.lungcan.2022.03.012

المؤلفون: Gibson, Adam E. J., Ahmed, Waqas, Longworth, Louise, Bennett, Bryan, Daumont, Melinda, Darlison, Liz

المصدر: Patient; Sep2024, Vol. 17 Issue 5, p551-563, 13p

المؤلفون: Griesinger, Frank, Pérol, Maurice, Girard, Nicolas, Durand-Zaleski, Isabelle S., Zacharias, Stefan, Bosquet, Lise, Jänicke, Martina, Quantin, Xavier, Groth, Annika, Fleitz, Annette, Calleja, Alan, Patel, Sonya, Lacoin, Laure, Daumont, Melinda Manley, Penrod, John R., Carroll, Robert, Waldenberger, Daniela, Reynaud, Dorothée, Thomas, Michael J., Chouaid, Christos

المساهمون: University of Oldenburg, Centre Léon Bérard Lyon, Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Institut Curie Paris, Centre for Research in Epidemiology and Statistics, Conservatoire National des Arts et Métiers CNAM (CNAM)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Methods of therapeutic evaluation of chronic diseases, Conservatoire National des Arts et Métiers CNAM (CNAM)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)-Conservatoire National des Arts et Métiers CNAM (CNAM)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), UNICANCER, Institut régional de Cancérologie de Montpellier (ICM), Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), German Center for Lung Research, Centre Hospitalier Intercommunal de Créteil (CHIC), IMRB - CEPIA/"Clinical Epidemiology And Ageing : Geriatrics, Primary Care and Public Health" Créteil (U955 Inserm - UPEC), Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Amgen, Bristol-Myers Squibb, BMS, Eli Lilly and Company, Pfizer, AstraZeneca, Novartis, Roche, Celgene, AbbVie, Boehringer Ingelheim, Takeda Pharmaceutical Company, TPC, Merck Sharp and Dohme, MSD, Cilag, LATITUDE (AXON Communications) provided medical writing services on behalf of the authors and Bristol Myers Squibb Pharmaceuticals Ltd. The authors thank the centres involved in the ESME-AMLC programme for providing the data and each ESME local coordinator for managing the project at the local level. Moreover, the authors also thank the central coordination team of Unicancer and the ESME-AMLC Scientific Committee members for their ongoing support. The authors thank all patients, physicians and study teams participating in the CRISP registry, and the CRISP Executive Committee for their medical leadership., CRISP is an AIO study (no. AIO-TRK-0315) conducted by AIO-Studien-gGmbH (sponsor) in cooperation with iOMEDICO (conception, project management and analysis) and supported by grants from Amgen Ltd., AstraZeneca GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Bristol Myers Squibb GmbH & Co. KGaA, Celgene GmbH, Janssen-Cilag GmbH, Lilly Deutschland GmbH, Merck Sharp & Dohme GmbH, Novartis Pharma GmbH, Pfizer Pharma GmbH, Roche Pharma AG, and Takeda Pharma Vertriebs GmbH & Co. KG., Michael Thomas reports honoraria for scientific meetings from Abbvie, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Chugai, Daichi Sankyo, GlaxoSmithKline, Janssen, Lilly, Merck, MSD, Novartis, Pfizer, Roche, Sanofi and Takeda, travel support from AbbVie, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Chugai, Lilly, MSD, Novartis, Pfizer, Roche and Takeda, honoraria for advisory boards from AbbVie, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Chugai, Janssen, Lilly, MSD, Novartis, Pfizer, Roche and Takeda, and institutional research grants from AstraZeneca, Bristol Myers Squibb, Roche and Takeda., The ESME-AMLC database received financial support from an industrial consortium (AstraZeneca, Merck Sharp & Dohme, Bristol Myers Squibb, Amgen and Roche). Unicancer manages the ESME database (i.e. data collection and analysis) independently., Christos Chouaid reports grants, personal fees and non-financial support from Amgen, AstraZeneca, Aventis, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, GlaxoSmithKline, Lilly, Merck Sharp & Dohme, Novartis, Pfizer, Roche, Sanofi and Takeda outside the submitted work., Annika Groth reports grants from Amgen, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Janssen-Cilag, Lilly, Merck Sharp & Dohme, Novartis, Pfizer, Roche, and Takeda to her employer AIO-Studien-gGmbH.

المصدر: ISSN: 0169-5002 ; Lung Cancer ; https://hal.science/hal-03837199 ; Lung Cancer, 2022, 172, pp.65-74. ⟨10.1016/j.lungcan.2022.08.001⟩.

مصطلحات موضوعية: Advanced non-small cell lung cancer, I-O Optimise, Real-world evidence, [SDV]Life Sciences [q-bio]

Relation: info:eu-repo/semantics/altIdentifier/pmid/36007281; PUBMED: 36007281

الاتاحة: https://hal.science/hal-03837199
https://hal.science/hal-03837199v1/document
https://hal.science/hal-03837199v1/file/PIIS0169500222005773.pdf
https://doi.org/10.1016/j.lungcan.2022.08.001

المؤلفون: Chouaid, Christos, Thomas, Michael, Debieuvre, Didier, Durand-Zaleski, Isabelle, Zacharias, Stefan, Bosquet, Lise, Groth, Annika, Fleitz, Annette, Calleja, Alan, Patel, Sonya, Lacoin, Laure, Daumont, Melinda, J, Penrod, John, R, Carroll, Robert, Waldenberger, Daniela, Cotté, François-Emery, Audigier-Valette, Clarisse, Griesinger, Frank

المساهمون: Centre Hospitalier Intercommunal de Créteil (CHIC), Translational Lung Research Center Heidelberg (TLRC), Heidelberg University Hospital Heidelberg, Centre Hospitalier Emile Muller Mulhouse (CH E.Muller Mulhouse), Groupe Hospitalier de Territoire Haute Alsace (GHTHA), Département de la Recherche Clinique et du Développement AP-HP Hôtel Dieu (DRCD-URC Eco), Unité de Recherche Clinique en Economie de la Santé d'Ile-de-France, Hôpital Hôtel-Dieu Paris, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Hôtel-Dieu Paris, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre for Research in Epidemiology and Statistics, Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), iOMEDICO, UNICANCER, AIO-Studien-gGmbH, Clinical Epidemiology and Health Economics, iOMEDICO, IQVIA, Bristol-Myers Squibb Company, Centre Hospitalier Intercommunal Toulon-La Seyne sur Mer - Hôpital Sainte-Musse, University of Oldenburg

المصدر: ISSN: 2072-6694.

مصطلحات موضوعية: nivolumab, non-small cell lung cancer, immune checkpoint inhibitor, clinical practice, I-O Optimise, real-world evidence, immunotherapy, programmed death-ligand, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie

Relation: info:eu-repo/semantics/altIdentifier/pmid/36551632; PUBMED: 36551632; PUBMEDCENTRAL: PMC9776880

الاتاحة: https://hal.u-pec.fr/hal-04141281
https://hal.u-pec.fr/hal-04141281v1/document
https://hal.u-pec.fr/hal-04141281v1/file/cancers-14-06148.pdf
https://doi.org/10.3390/cancers14246148

المؤلفون: Sørensen, Jens Benn, Horvat, Pia, Rosenlund, Mats, Kejs, Anne Mette, Patel, Dony, Juarez-Garcia, Ariadna, Lacoin, Laure, Daumont, Melinda J., Penrod, John R., O'donnell, John C., Brustugun, Odd Terje, Ekman, Simon

المصدر: Sørensen , J B , Horvat , P , Rosenlund , M , Kejs , A M , Patel , D , Juarez-Garcia , A , Lacoin , L , Daumont , M J , Penrod , J R , O'donnell , J C , Brustugun , O T & Ekman , S 2022 , ' Initial treatment and survival in Danish patients diagnosed with non-small-cell lung cancer (2005-2015) : SCAN-LEAF study ' , Future Oncology , vol. 18 , no. 2 , pp. 205-214 . https://doi.org/10.2217/fon-2021-0746

مصطلحات موضوعية: I-O Optimise initiative, NSCLC, overall survival, registry, SCAN-LEAF, time trends, treatment

وصف الملف: application/pdf

الاتاحة: https://curis.ku.dk/portal/da/publications/initial-treatment-and-survival-in-danish-patients-diagnosed-with-nonsmallcell-lung-cancer-20052015(7d1df2d5-fc59-457a-a503-1d88b5c1629c).html
https://doi.org/10.2217/fon-2021-0746
https://curis.ku.dk/ws/files/318201527/Initial_treatment_and_survival_in_Danish_patients_diagnosed_with_non_small_cell_lung_cancer.pdf
http://www.scopus.com/inward/record.url?scp=85121582602&partnerID=8YFLogxK

المؤلفون: Moore, Adam, Bennett, Bryan, Taylor-Stokes, Gavin, McDonald, Laura, Daumont, Melinda J.

المصدر: BMC Cancer ; volume 22, issue 1 ; ISSN 1471-2407

الاتاحة: http://dx.doi.org/10.1186/s12885-022-09750-7
https://link.springer.com/content/pdf/10.1186/s12885-022-09750-7.pdf
https://link.springer.com/article/10.1186/s12885-022-09750-7/fulltext.html

المؤلفون: Carroll, Robert, Bortolini, Margherita, Calleja, Alan, Munro, Robin, Kong, Shiying, Daumont, Melinda J., Penrod, John R., Lakhdari, Khalid, Lacoin, Laure, Cheung, Winson Y.

المصدر: BMC Cancer ; volume 22, issue 1 ; ISSN 1471-2407

الاتاحة: http://dx.doi.org/10.1186/s12885-022-09342-5
https://link.springer.com/content/pdf/10.1186/s12885-022-09342-5.pdf
https://link.springer.com/article/10.1186/s12885-022-09342-5/fulltext.html

المؤلفون: Mansfield, Aaron S., Brown, Rebecca J., Sammon, Cormac, Daumont, Melinda J., McKenna, Mike, Sanzari, Jenine K., Forde, Patrick M.

المساهمون: Bristol-Myers Squibb Co

المصدر: JTO Clinical and Research Reports ; volume 3, issue 5, page 100315 ; ISSN 2666-3643

الاتاحة: http://dx.doi.org/10.1016/j.jtocrr.2022.100315
https://api.elsevier.com/content/article/PII:S266636432200039X?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S266636432200039X?httpAccept=text/plain

المؤلفون: Danese, Mark D., Daumont, Melinda, Nwokeji, Esmond, Gleeson, Michelle, Penrod, John R., Lubeck, Deborah

المساهمون: Bristol Myers Squibb

المصدر: Cancer Reports ; volume 5, issue 9 ; ISSN 2573-8348 2573-8348

الاتاحة: http://dx.doi.org/10.1002/cnr2.1568
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cnr2.1568
https://onlinelibrary.wiley.com/doi/full-xml/10.1002/cnr2.1568

المؤلفون: Snee, Michael, Cheeseman, Sue, Thompson, Matthew, Riaz, Majid, Sopwith, Will, Lacoin, Laure, Chaib, Carlos, J Daumont, Melinda, Penrod, John R, O’Donnell, John C, Hall, Geoff

المساهمون: Bristol Myers Squibb Company

المصدر: BMJ Open ; volume 11, issue 5, page e043442 ; ISSN 2044-6055 2044-6055

الاتاحة: http://dx.doi.org/10.1136/bmjopen-2020-043442
https://syndication.highwire.org/content/doi/10.1136/bmjopen-2020-043442

المؤلفون: Snee, Michael, Cheeseman, Sue, Thompson, Matthew, Riaz, Majid, Sopwith, Will, Lacoin, Laure, Chaib, Carlos, Daumont, Melinda J, Penrod, John R, Hall, Geoff

المساهمون: Bristol Myers Squibb

المصدر: BMJ Open ; volume 11, issue 9, page e046396 ; ISSN 2044-6055 2044-6055

الاتاحة: http://dx.doi.org/10.1136/bmjopen-2020-046396
https://syndication.highwire.org/content/doi/10.1136/bmjopen-2020-046396

المؤلفون: Waterhouse, David M, Nwokeji, Esmond D, Boyd, Marley, Penrod, John R, Espirito, Janet L, Robert, Nicholas J, Daumont, Melinda J

المساهمون: Bristol Myers Squibb

المصدر: Future Oncology ; volume 17, issue 19, page 2439-2448 ; ISSN 1479-6694 1744-8301

الاتاحة: http://dx.doi.org/10.2217/fon-2021-0047
https://www.tandfonline.com/doi/pdf/10.2217/fon-2021-0047

المؤلفون: Soares, Marta, Antunes, Luís, Redondo, Patrícia, Borges, Marina, Hermans, Ruben, Patel, Dony, Grimson, Fiona, Munro, Robin, Chaib, Carlos, Lacoin, Laure, Daumont, Melinda, Penrod, John R, O’Donnell, John C, Bento, Maria José, Gonçalves, Francisco Rocha

المساهمون: Bristol Myers Squibb

المصدر: Lung Cancer Management ; volume 10, issue 2 ; ISSN 1758-1966 1758-1974

الاتاحة: http://dx.doi.org/10.2217/lmt-2020-0028
https://www.tandfonline.com/doi/pdf/10.2217/lmt-2020-0028

المؤلفون: Ekman, Simon, Horvat, Pia, Rosenlund, Mats, Kejs, Anne Mette, Patel, Dony, Juarez-Garcia, Ariadna, Lacoin, Laure, Daumont, Melinda J., Penrod, John R., Brustugun, Odd Terje, Sørensen, Jens Benn

المساهمون: Novartis, Pfizer, Roche, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Takeda Pharmaceutical Company, Eli Lilly and Company, Merck Sharp and Dohme, GlaxoSmithKline, Les Laboratories Pierre Fabre

المصدر: JTO Clinical and Research Reports ; volume 2, issue 5, page 100165 ; ISSN 2666-3643

الاتاحة: http://dx.doi.org/10.1016/j.jtocrr.2021.100165
https://api.elsevier.com/content/article/PII:S2666364321000242?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S2666364321000242?httpAccept=text/plain